Covalon Technologies (TSXV:COV) announced today that it named Amir Boloor as interim CEO following the departure of Brian Pedlar.
Boloor serves as chair of the company’s board. As he takes on an executive role, the board appointed Joseph Cordiano to serve as lead independent director.
Mississauga, Ontario-based Covalon commenced a search for a permanent CEO. Pedlar remains on the company’s board of directors.
“On behalf of the entire board, I would like to sincerely thank Brian for his leadership during his more than 13-year tenure, including the company’s evolution from a research and development-centric company to a product-centric company. He set the stage for Covalon’s next phase of growth,” said Boloor. “We look forward to receiving his continued advice and wish him much success in his future endeavors.”
Martin Goldfarb, board member and one of Covalon’s largest shareholders, said Boloor brings a “deep understanding” of the company. As an experienced CEO, Goldfarb said, Boloor is well-placed to oversee the continued execution of the company’s strategy.
Covalon develops technologies and solutions for advanced wound care, infection prevention, and medical device coatings.
“I look forward to the opportunity to serve in this role while the board conducts a search for Covalon’s next CEO,” Boloor said. “I am looking forward to partnering with Covalon’s leadership team to ensure we continue to execute on behalf of all our stakeholders, including our clients, our staff and our shareholders.”